Jump Financial, LLC Harmony Biosciences Holdings, Inc. Transaction History

Jump Financial, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$29.93 - $35.06 $1.13 Million - $1.33 Million	37,904 New	37,904 $1.27 Million
Q4 2022 Feb 13, 2023	BUY	$45.4 - $60.91 $354,120 - $475,098	7,800 Added 22.87%	41,900 $2.31 Million
Q3 2022 Nov 07, 2022	BUY	$42.06 - $55.45 $1.43 Million - $1.89 Million	34,100 New	34,100 $1.51 Million
Q2 2022 Aug 09, 2022	SELL	$33.54 - $52.15 $1.74 Million - $2.7 Million	-51,786 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$33.14 - $51.13 $1.13 Million - $1.74 Million	34,106 Added 192.91%	51,786 $2.52 Million
Q4 2021 Feb 10, 2022	SELL	$34.09 - $43.91 $1.25 Million - $1.61 Million	-36,750 Reduced 67.52%	17,680 $754,000
Q3 2021 Nov 12, 2021	BUY	$25.68 - $38.61 $640,844 - $963,512	24,955 Added 84.66%	54,430 $2.09 Million
Q2 2021 Aug 13, 2021	BUY	$25.96 - $33.44 $570,471 - $734,844	21,975 Added 293.0%	29,475 $832,000
Q1 2021 May 17, 2021	BUY	$27.56 - $40.37 $206,700 - $302,775	7,500 New	7,500 $248,000

242

45.1M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.08B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.